John Rieth
Clinical trials sponsored by John Rieth, explained in plain language.
-
Virus therapy tested to shrink tough tumors before surgery
Disease control OngoingThis study is testing whether injecting a modified virus (talimogene laherparepvec) directly into a tumor, along with standard radiation therapy, is safe and effective for patients with advanced soft tissue sarcoma before they have surgery. The goal is to see if this combination …
Phase: PHASE1, PHASE2 • Sponsor: John Rieth • Aim: Disease control
Last updated Apr 02, 2026 01:56 UTC
-
Modified virus and radiation team up to shrink tough tumors before surgery
Disease control OngoingThis study is testing a two-part treatment for people with locally advanced soft tissue sarcomas, a type of cancer. Before surgery, patients receive a modified virus injected directly into the tumor along with standard radiation therapy. The goal is to see if this combination can…
Phase: PHASE2 • Sponsor: John Rieth • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC